In the pathogenesis of breast cancer, the activation of the cGAS-STING signaling pathway plays a crucial role in enhancing antitumor immune responses, thereby suppressing the progression and metastasis of breast cancer, offering new potential strategies for immunotherapy in breast cancer (33). This evidence concerns the gene STING1 and breast cancer.